Adakveo 欧州連合 - クロアチア語 - EMA (European Medicines Agency)

adakveo

novartis europharm limited - crizanlizumab - anemija, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Diclorapid 75 mg želučanootporne kapsule, tvrde クロアチア - クロアチア語 - HALMED (Agencija za lijekove i medicinske proizvode)

diclorapid 75 mg želučanootporne kapsule, tvrde

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - diklofenaknatrij - želučanootporna kapsula, tvrda - 75 mg - urbroj: jedna tvrda želučanootporna kapsula sadrži 75 mg diklofenaknatrija